| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00488774 NCT01842152 2006-003397-94 Details | 2013-06-14 Interventional | 2/3 | 291 | Antibodies, Mon… Golimumab Colitis Colitis, Ulcera… Ulcer | Protocol was cancelled by company based on overall efficacy, no safety concern Data collection was not considered complete for primary outcome measure because study was terminated prematurely. | |||
| NCT01091051 Details | 2013-06-11 Interventional | 3 | 33 | Ustekinumab Psoriasis Palmo-Plantar P… Palmo-Plantar P… | Manufacturer ceased to produce vials used for this study. - | |||
| NCT00555464 Details | 2013-06-11 Interventional | 2 | 8 | Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Prednisone Vincristine Hemangioma | The introduction of oral propranolol as a highly efficacious agent for infantile hemangiomas The limitations of this trial include early termination of enrollment leading to small numbers of subjects analyzed. | |||
| NCT01095094 NCT00792987 Details | 2013-06-10 Interventional | 2 | 19 | Lopinavir Ritonavir Astrocytoma Brain Neoplasms Ependymoma Glioblastoma Glioma Gliosarcoma Oligodendroglio… Anaplastic Astr… Anaplastic Epen… Anaplastic Olig… Brain Stem Glio… Brain Tumor Giant Cell Glio… Mixed Glioma | Study did not meet its primary objective - | |||
| NCT00687388 Details | 2013-06-10 Interventional | 4 | 0 | Adrenergic alph… Alfuzosin Celecoxib Doxazosin Prazosin Tamsulosin Terazosin Hyperplasia Inflammation Prostatic Hyper… Benign Prostati… | in order to prepare a new clinical trial to evaluate with pathological change - | |||
| NCT00006096 Details | 2013-06-10 Interventional | 3 | - | Cisplatin Vulvar Neoplasm… Vulvar Cancer | - - | |||
| NCT00003382 Details | 2013-06-10 Interventional | 1 | [1 Refs] | - | Gemcitabine Topotecan Carcinoma, Ovar… Fallopian Tube … Ovarian Neoplas… Fallopian Tube … Ovarian Cancer Primary Periton… | - - | ||
| NCT00003380 Details | 2013-06-10 Interventional | 1 | - | Doxorubicin Etoposide Liposomal doxor… Fallopian Tube … Fallopian Tube … Ovarian Cancer Primary Periton… | - - | |||
| NCT00003179 Details | 2013-06-10 Interventional | 2 | [2 Refs] | - | Medroxyprogeste… Medroxyprogeste… Endometrial Neo… Endometrial Can… | - - | ||
| NCT00002478 Details | 2013-06-10 Interventional | 2 | [3 Refs] | - | Etoposide Uterine Cervica… Cervical Cancer Ovarian Cancer | - - | ||
| NCT00793858 Details | 2013-06-07 Interventional | 4 | 0 | Ciclesonide Rhinitis Rhinitis, Aller… Allergic Rhinit… | Cost prohibitive and company withdrew support. - | |||
| NCT00307099 Details | 2013-06-07 Interventional | 3 | - | Anti-Bacterial … Meropenem Bacterial Infec… Bacterial Infec… | - - | |||
| NCT01238146 Details | 2013-06-06 Interventional | 1/2 | 0 | Bendamustine Hy… Obatoclax Rituximab Lymphoma Lymphoma, B-Cel… Lymphoma, B-Cel… Lymphoma, Folli… Lymphoma, Mantl… Lymphoma, Non-H… Recurrence Extranodal Marg… Nodal Marginal … Recurrent Grade… Recurrent Grade… Recurrent Mantl… Recurrent Margi… Splenic Margina… | No patients accrued. - | |||
| NCT00303836 NCT00255203 Details | 2013-06-06 Interventional | 2 | 58 | Aldesleukin Cyclophosphamid… Fludarabine Fludarabine pho… Freund's Adjuva… Interleukin-2 Melanoma Recurrent Melan… Stage IV Melano… | - - | |||
| NCT00087269 Details | 2013-06-06 Interventional | 2 | 110 | Erlotinib Hydro… Carcinoma, Non-… Lung Neoplasms Stage IA Non-sm… Stage IB Non-sm… Stage IIA Non-s… Stage IIB Non-s… Stage IIIA Non-… | - - | |||
| NCT00009984 Details | 2013-06-06 Interventional | 2 | 70 | Fludarabine Fludarabine pho… Thalidomide Leukemia Leukemia, Lymph… Leukemia, Lymph… Recurrent Small… Refractory Chro… | - - | |||
| NCT00091078 Details | 2013-06-05 Interventional | 2 | 96 | Imatinib Mesyla… Oblimersen Gastrointestina… Gastrointestina… | - - | |||
| NCT01351038 Details | 2013-06-04 Interventional | 2 | - | Capecitabine Epirubicin Oxaliplatin Panitumumab Adenocarcinoma KRAS Wild Type Resectable Type… | REAL trial showed a significant difference in OS for reduced EOX and standard EOX - | |||
| NCT00406874 Details | 2013-06-04 Interventional | 2 | 6 | Folic Acid Infertility | reports indicating that increased folic acid intake may increase colin cancer - | |||
| NCT00103272 Details | 2013-06-04 Interventional | 1 | 74 | Bortezomib Hypereosinophil… Immunoblastic L… Leukemia Leukemia, Basop… Leukemia, Eosin… Leukemia, Eryth… Leukemia, Lymph… Leukemia, Megak… Leukemia, Monoc… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Leukemia, T-Cel… Leukemia-Lympho… Lymphoma Lymphoma, B-Cel… Lymphoma, B-Cel… Lymphoma, Folli… Lymphoma, Large… Lymphoma, Large… Lymphoma, Mantl… Lymphoma, Non-H… Lymphoma, T-Cel… Lymphoma, T-Cel… Mycoses Mycosis Fungoid… Precursor Cell … Recurrence Sezary Syndrome Waldenstrom Mac… Adult Acute Bas… Adult Acute Eos… Adult Acute Meg… Adult Acute Min… Adult Acute Mon… Adult Acute Mon… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Erythrole… Adult Pure Eryt… Anaplastic Larg… Angioimmunoblas… Extranodal Marg… Nodal Marginal … Recurrent Adult… Recurrent Adult… Recurrent Adult… Recurrent Adult… Recurrent Cutan… Recurrent Grade… Recurrent Grade… Recurrent Grade… Recurrent Mantl… Recurrent Margi… Recurrent Mycos… Recurrent Small… Refractory Chro… Small Intestine… Splenic Margina… Waldenström Ma… | - - |